TokenPost·
Tandem Diabetes Care Sets 2026 Sales Outlook at $1.065 Billion to $1.085 Billion
The company also projected gross margins of 56% to 57% and adjusted EBITDA margins of 5% to 6%.
More news
- TokenPostJames Hardie Raises FY2027 Free Cash Flow Target Above $650 Million
- CryptoSlateZcash’s new security fund is 99.7% old money
- TokenPostEl Pollo Loco Plans 25 to 30 Restaurant Openings for 2027
- TokenPostGildan Withdraws 2026-2028 Goals, Forecasts $700 Million to $750 Million in Free Cash Flow
- TokenPostJeff Park Warns Anthropic Could Spiral If IPO Fails to Lift Value
- TokenPostCanadian Apartment Properties Real Estate Investment Trust Plans 1.2B in 2026 Refinancing